Skip to main content
Clinical Trials/NL-OMON47032
NL-OMON47032
Completed
Not Applicable

Impact of dementia-related neurodegeneration on pain processing - Pain processing in dementia

Huisartsgeneeskunde0 sites125 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Alzheimer desease
Sponsor
Huisartsgeneeskunde
Enrollment
125
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational invasive

Investigators

Sponsor
Huisartsgeneeskunde

Eligibility Criteria

Inclusion Criteria

  • In order to be eligible to participate in this study, a subject must meet all of the following criteria:;All subjects:
  • \- Age from 55 \* 85 yr
  • \- Willingness to cooperate and sign written informed consent \* or proxy consent with assent of participating subject;Normal Healthy Controls (CP):
  • \- MMSE scores between 27\-30
  • \- Without subjective memory complaints;Alzheimers\*s disease dementia (AD):
  • \- Diagnosis of probable AD according to the Alzheimer\*s disease and Related Disorders Associations (NINCDS\-ADRDA) criteria and NIA\-AA guidelines ( McKhann et al. 2011\).;Frontotemporal dementia (FTD):
  • \- Diagnosis of behavioral variant FTD (FTD\-b) according to the revised consensus criteria (Rascovsky et al. 2011\).
  • \- Diagnosis of a subtype of FTD of Primary Progressive Aphasia (PPA), divided into Semantic Dementia (SD), Progressive Nonfluent Aphasia (PNFA) and LPA due to FTD (Gorno\-Tempini et al. 2011\). ;Vascular dementia (VD):
  • \- Diagnosis of probable VD according to the NINDS\-AIREN (National Institute of Neurological Disorders and Stroke and the Association Internationale pour la Recherche et l\*Enseignement en Neurosciences) guidelines (Roman et al. 1993\).

Exclusion Criteria

  • All subjects:
  • \- History of major psychiatric illness
  • \- Medications which may affect pain processing (selective serotonin re\-uptake inhibitors, opioids, other analgesics)
  • \- Contraindications for MR\-measurements (e.g. cochlear implants and most permanent pacemakers, red tattoos);Normal healthy Controls:
  • \- abnormal results on neuropsychological tests
  • \- subjective memory complaints;All patients:
  • \- Cognitive deficits could be explained by non\-neurodegenerative condition (e.g. stroke, neoplasm, head injury, hydrocephalus or other medical condition)

Outcomes

Primary Outcomes

Not specified

Similar Trials